0000899243-23-010212.txt : 20230403
0000899243-23-010212.hdr.sgml : 20230403
20230403160514
ACCESSION NUMBER: 0000899243-23-010212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reinhart Harald
CENTRAL INDEX KEY: 0001835824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 23792597
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR
STREET 2: PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001704292
Zai Lab Ltd
ZLAB
0001835824
Reinhart Harald
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
0
1
0
0
See Remarks
0
American Depositary Shares
2023-03-31
4
M
0
1010
33.26
A
19968
D
American Depositary Shares
2023-03-31
4
F
0
246
33.26
D
19722
D
American Depositary Shares
2023-03-31
4
M
0
3338
33.26
A
23060
D
American Depositary Shares
2023-03-31
4
F
0
813
33.26
D
22247
D
Restricted Share Units
2023-03-31
4
M
0
3338
0.00
D
American Depositary Shares
3338
13354
D
Restricted Share Units
2023-03-31
4
M
0
1010
0.00
D
American Depositary Shares
1010
3030
D
Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer.
This transaction represents the disposition of shares to cover taxes.
Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases
/s/ Bruce Blefeld, Attorney-in-Fact
2023-04-03